投资+改善生活!毛戈平:拟减持超14亿港元!
证券时报·2026-01-07 10:40

Core Viewpoint - The founding family of Maogeping Cosmetics plans to collectively reduce their shareholding after the stock price has doubled since its listing, indicating a normal financial arrangement rather than a lack of confidence in the company's future [1][2]. Group 1: Shareholding Reduction - On January 6, Maogeping announced that its controlling shareholders intend to reduce their holdings by up to 17.2 million H shares, representing 3.51% of the total issued shares, primarily through block trades within six months [1]. - The planned cash-out amount is approximately HKD 1.41 billion, based on the closing price of HKD 82 per share on January 6 [2]. - Despite the reduction announcement, the stock price increased by over 8% on the day of the announcement, closing at HKD 87.95, reflecting a market reaction that is considered rational [2]. Group 2: Company Performance - Maogeping has shown strong financial growth, with a revenue of CNY 2.588 billion for the first half of 2025, a year-on-year increase of 31.3%, and a net profit of CNY 670 million, up 36.1% [4]. - For the full year of 2024, the company reported revenues of CNY 3.885 billion, a 34.61% increase, and a net profit of CNY 881 million, growing by 32.8% [4]. - The company's gross margin has consistently remained above 80%, with figures of 83.4%, 83.8%, 84.8%, 84.4%, and 84.2% from 2021 to the first half of 2025 [4]. Group 3: Strategic Initiatives - The company is actively expanding its product offerings and distribution channels, including entering high-end department stores and enhancing its online presence through platforms like Tmall and Douyin [5]. - A restricted stock incentive plan has been proposed to strengthen the long-term incentive mechanism for core employees, aligning their interests with those of shareholders [5]. - Analysts from Everbright Securities and Huayuan Securities express optimism about the company's high-end positioning and growth potential, forecasting net profits of CNY 1.21 billion, CNY 1.58 billion, and CNY 2.04 billion for 2025 to 2027 [5].